SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-16-007356
Filing Date
2016-05-12
Accepted
2016-05-12 16:03:15
Documents
35
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT opxa_10q.htm 10-Q 635047
2 CERTIFICATION opxa_ex311.htm EX-31.1 16009
3 CERTIFICATION opxa_ex321.htm EX-32.1 8268
10 logo.jpg GRAPHIC 2618
  Complete submission text file 0001354488-16-007356.txt   1696696

Data Files

Seq Description Document Type Size
4 opxa-20160331.xml EX-101.INS 123333
5 opxa-20160331.xsd EX-101.SCH 28219
6 opxa-20160331_cal.xml EX-101.CAL 32697
7 opxa-20160331_def.xml EX-101.DEF 37754
8 opxa-20160331_lab.xml EX-101.LAB 171414
9 opxa-20160331_pre.xml EX-101.PRE 116373
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 161643687
SIC: 2834 Pharmaceutical Preparations